Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein.
暂无分享,去创建一个
M Fujita | T. Akiyama | M. Fujita | T. Kiyono | A. Hiraiwa | T Akiyama | T Kiyono | A Hiraiwa | Y Hayashi | M Ishibashi | Y. Hayashi | M. Ishibashi | Y. Hayashi
[1] M. Scheffner,et al. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. , 1991, The EMBO journal.
[2] John Calvin Reed,et al. FAP-1: a protein tyrosine phosphatase that associates with Fas. , 1995, Science.
[3] John H. Lewis,et al. Crystal Structures of a Complexed and Peptide-Free Membrane Protein–Binding Domain: Molecular Basis of Peptide Recognition by PDZ , 1996, Cell.
[4] S. S. Lee,et al. Binding of human virus oncoproteins to hDlg/SAP97, a mammalian homolog of the Drosophila discs large tumor suppressor protein. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[5] G. Demers,et al. The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells , 1991, Journal of virology.
[6] M. Kennedy,et al. The rat brain postsynaptic density fraction contains a homolog of the drosophila discs-large tumor suppressor protein , 1992, Neuron.
[7] P. Seeburg,et al. Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95. , 1995, Science.
[8] S. Ishii,et al. Inhibition of p53-mediated transactivation by E6 of type 1, but not type 5, 8, or 47, human papillomavirus of cutaneous origin , 1994, Journal of virology.
[9] A. Matus,et al. A novel strategy for the immunological tagging of cDNA constructs. , 1993, Gene.
[10] R. Elston,et al. Interaction of the E6 protein of human papillomavirus with cellular proteins. , 1994, Oncogene.
[11] M. Braun,et al. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines , 1987, Journal of virology.
[12] Galloway Da,et al. HUMAN PAPILLOMAVIRUS TYPE 16 E7 ALLEVIATES A PROLIFERATION BLOCK IN EARLY PASSAGE HUMAN MAMMARY EPITHELIAL CELLS , 1996 .
[13] D. Branton,et al. Cloning and characterization of hdlg: the human homologue of the Drosophila discs large tumor suppressor binds to protein 4.1. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[14] P. Krieg,et al. Papillomavirus genomes in human cervical tumors: analysis of their transcriptional activity. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[15] M. Kozak. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes , 1986, Cell.
[16] K. Vousden,et al. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation , 1991, Cell.
[17] J. Shay,et al. E6 of human papillomavirus type 16 can overcome the M1 stage of immortalization in human mammary epithelial cells but not in human fibroblasts. , 1993, Oncogene.
[18] M. Scheffner,et al. Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53 , 1993, Molecular and cellular biology.
[19] K. Kinzler,et al. The multistep nature of cancer. , 1993, Trends in genetics : TIG.
[20] J. Garcia,et al. Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus , 1991, Journal of virology.
[21] D. Smith,et al. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. , 1988, Gene.
[22] K. Münger,et al. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. , 1989, Science.
[23] D. Lowy,et al. Mutant p53 can substitute for human papillomavirus type 16 E6 in immortalization of human keratinocytes but does not have E6-associated trans-activation or transforming activity , 1992, Journal of virology.
[24] M. Yutsudo,et al. Correlation between Tumorigenicity and Expression Levels or Splicing Patterns of Transcripts of the Human Papillomavirus Type 16 E6 Gene , 1994, Japanese journal of cancer research : Gann.
[25] K. Segawa,et al. Comparative study on E6 and E7 genes of some cutaneous and genital papillomaviruses of human origin for their ability to transform 3Y1 cells. , 1993, Virology.
[26] H. Pan,et al. Temporally distinct patterns of p53-dependent and p53-independent apoptosis during mouse lens development. , 1995, Genes & development.
[27] R. Schlegel,et al. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes , 1989, Journal of virology.
[28] J. Yee,et al. Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus , 1991, Journal of virology.
[29] S. Nagata,et al. pEF-BOS, a powerful mammalian expression vector. , 1990, Nucleic acids research.
[30] L. Cantley,et al. Recognition of Unique Carboxyl-Terminal Motifs by Distinct PDZ Domains , 1997, Science.
[31] T. Akiyama,et al. Binding of APC to the Human Homolog of the Drosophila Discs Large Tumor Suppressor Protein , 1996, Science.
[32] F. Wettstein,et al. Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[33] D. Bredt,et al. Interaction of Nitric Oxide Synthase with the Postsynaptic Density Protein PSD-95 and α1-Syntrophin Mediated by PDZ Domains , 1996, Cell.
[34] E. Androphy,et al. Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein. , 1995, Science.
[35] G. Demers,et al. The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest , 1994, Journal of virology.
[36] M. Scheffner,et al. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53 , 1993, Cell.
[37] A. Blondel,et al. Export and purification of a cytoplasmic dimeric protein by fusion to the maltose-binding protein of Escherichia coli. , 1990, European journal of biochemistry.
[38] Arnold J. Levine,et al. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 , 1990, Cell.
[39] S. Gomperts,et al. Clustering Membrane Proteins: It's All Coming Together with the PSD-95/SAP90 Protein Family , 1996, Cell.
[40] V. Band,et al. Loss of p53 protein in human papillomavirus type 16 E6-immortalized human mammary epithelial cells , 1991, Journal of virology.
[41] Wolfgang Mayer,et al. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells , 1985, Nature.
[42] D. Lowy,et al. HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. , 1989, The EMBO journal.
[43] M. Scheffner,et al. Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins , 1993, Molecular and cellular biology.
[44] Peter J. Bryant,et al. The discs-large tumor suppressor gene of Drosophila encodes a guanylate kinase homolog localized at septate junctions , 1991, Cell.
[45] A. Levine,et al. Association of human papillomavirus types 16 and 18 E6 proteins with p53. , 1990, Science.